secwatch.observer — SEC 8-K summary
======================================

Issuer:     VYNE Therapeutics Inc. (VYNE)
CIK:        0001566044
Form:       8-K
Filed at:   2026-07-21T12:14:41+00:00
Accession:  0001104659-26-085235
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

VYNE announces 1-for-50 reverse stock split and $17.3M special dividend for Yarrow merger
--------------------------------------------------------------------------------

- Reverse stock split at 1-for-50 reduces outstanding shares from ~33.4M to ~0.7M.
- Aggregate special cash dividend of $17.3M ($0.40242/share) payable July 23 to holders of record July 22.
- Merger with Yarrow Bioscience expected to close July 24; combined company to trade as YARW on Nasdaq on July 27.
- Post-merger combined company shares: ~2.7M basic, ~33.6M fully diluted.
- Stockholders approved reverse split and increase in authorized shares from 150M to 300M at July 16 special meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1566044/000110465926085235/0001104659-26-085235-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1566044/000110465926085235/tm2620874d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-085235

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer